Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study.
about
Organizing Pneumonia in Rheumatoid Arthritis Patients: A Case-Based ReviewThe role of ultrasound in diagnosing rheumatoid arthritis, what do we know? An updated review.Strategies to predict rheumatoid arthritis development in at-risk populations.Views on clinically suspect arthralgia: a focus group studyT cell subsets: an immunological biomarker to predict progression to clinical arthritis in ACPA-positive individualsPreclinical Rheumatoid Arthritis: Progress Toward Prevention.Novel algorithms for the pragmatic use of ultrasound in the management of patients with rheumatoid arthritis: from diagnosis to remission.Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis.Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis.Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms - a cohort study.Absence of ultrasound inflammation in patients presenting with arthralgia rules out the development of arthritis.Which patients presenting with arthralgia eventually develop rheumatoid arthritis? The current state of the art.Profiling microRNAs in individuals at risk of progression to rheumatoid arthritis.Preventing progression from arthralgia to arthritis: targeting the right patients.Genetic and environmental risk factors for rheumatoid arthritis.The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgia.The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis.Comorbidities in Anti-Cyclic Citrullinated Peptide Positive At-Risk Individuals Do Not Differ from Those Patients with Early Inflammatory Arthritis.Anti-CarP antibodies as promising marker to measure joint damage and disease activity in patients with rheumatoid arthritis.The therapeutic window of opportunity in rheumatoid arthritis: does it ever close?Initial validation and results of the Symptoms in Persons At Risk of Rheumatoid Arthritis (SPARRA) questionnaire: a EULAR project.Survivin Measurement improves Clinical Prediction of Transition From Arthralgia to RA-Biomarkers to Improve Clinical Sensitivity of Transition From Arthralgia to RA
P2860
Q26778887-7DDA53D8-34CC-4464-AEE4-EC572BD093FEQ36179836-B5899FEB-A9D8-4C97-BDD6-A687DDB1BA70Q36366153-9A553A09-F945-43DB-8C5F-7470FEDE2A36Q36834508-E32A93FE-97BD-40A0-B426-3D7872A5E59BQ37282514-A2D0519A-9699-4D9D-B198-DE0AC0E51930Q38712937-A5CF20A5-4353-41E9-BB3D-A9336A2A3C7EQ38935035-53C4845A-A883-4184-A205-E8F66E7454E7Q40070759-E7C0758B-A092-42E2-BF22-952C0E1C0351Q40267448-E37097B0-4645-4764-9C5D-C5542BF7124EQ40513222-391732E2-E7C0-498F-8E81-A955C4F3B29AQ41711322-83F50599-6725-43F8-AF93-FF0B22F12501Q46720103-CDE2F976-F420-4E44-82F9-91EC0AA2D90CQ47120186-5E09887A-06CC-486B-A2F0-EB811E9BB161Q47423382-601456CC-6F46-4412-B4EE-0E2B6D10C564Q47563245-8598F79C-1C32-4AB8-B949-4696FEA33876Q47714795-40356A5E-0469-4EF7-87D0-05FF8489999FQ50308665-E6E032BA-7DAD-4270-9784-CB2722E7F833Q52667978-BF749532-FC7D-4B8E-A8B7-718418159643Q53393095-486B2F34-1396-4E01-A2F8-AE9CA8344C75Q53583410-48ED2B23-4074-4014-9F5E-E700B4325A96Q54957848-E5CE7B3E-C43A-4C90-83BE-F46518B895AFQ58803456-A8B28AAA-E930-42E3-9409-10F8C406336F
P2860
Predicting the development of clinical arthritis in anti-CCP positive individuals with non-specific musculoskeletal symptoms: a prospective observational cohort study.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Predicting the development of ...... ve observational cohort study.
@en
Predicting the development of ...... ve observational cohort study.
@en-gb
Predicting the development of ...... ve observational cohort study.
@nl
type
label
Predicting the development of ...... ve observational cohort study.
@en
Predicting the development of ...... ve observational cohort study.
@en-gb
Predicting the development of ...... ve observational cohort study.
@nl
prefLabel
Predicting the development of ...... ve observational cohort study.
@en
Predicting the development of ...... ve observational cohort study.
@en-gb
Predicting the development of ...... ve observational cohort study.
@nl
P2093
P2860
P50
P1154
2-s2.0-84942099026
P1476
Predicting the development of ...... ve observational cohort study.
@en
P2093
E Villeneuve
L-A Bissell
P2860
P304
P356
10.1136/ANNRHEUMDIS-2014-205227
P407
P50
P5530
P577
2014-04-12T00:00:00Z
P5875
P6179
1032027825